lilly

Showing 15 posts of 211 posts found.

Lilly appoints new chief ethics and compliance officer and senior VP

October 30, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Melissa Barnes, lilly

Eli Lilly has announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president …

lilly corporate hq image

Lilly censured for rep photo

October 25, 2012
Medical Communications, Sales and Marketing ABPI, GP, PMCPA, lilly

Lilly has breached the ABPI’s Code of Practice because one of its representatives insisted on taking pictures of doctors underneath …

lilly corporate hq image

New drugs for Alzheimer’s trial

October 15, 2012
Research and Development, Sales and Marketing Alzheimer's, Roche, lilly

Roche and Eli Lilly are providing drugs free of charge to US investigators conducting a worldwide trial of Alzheimer’s disease …

Cialis image

New possibility for Lilly erectile drug

September 24, 2012
Sales and Marketing CHMP, Cialis, ED, hyperplasia, lilly

Eli Lilly’s erectile disfunction (ED) brand Cialis has been recommended to treat benign prostatic hyperplasia (BPH) in Europe. If the …

Online programme to help diabetes patients

September 14, 2012
Medical Communications, Sales and Marketing Boehringer, diabetes, lilly

Boehringer Ingelheim and Eli Lilly have launched an online initiative which they say will help diabetes sufferers make simple lifestyle …

lilly corporate hq image

Lilly suffers late-stage cancer blow

September 10, 2012
Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …

lilly_corporate_hq

Lilly’s Alzheimer’s drug fails in phase III

August 24, 2012
Sales and Marketing Alzheimer's, EXPEDITION, lilly, solanezumab

 Lilly has announced that its Alzheimer’s drug candidate solanezumab has failed its primary endpoints in two key phase III trials. …

FDA image

FDA approves leukaemia drug Marqibo

August 10, 2012
Sales and Marketing FDA, Marqibo, Talon Therapeutics, lilly

The Food and Drug Administration has given the green light for Talon Therapeutics’ Marqibo to combat a rare form of …

R&D, East & West: Lilly invests in its global research network

July 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly

Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …

Amylin withheld safety data, says FDA

June 27, 2012
Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, FDA, lilly

The US medicines regulator says Amylin held back data relating to the safety of its diabetes drug Bydureon. The allegation …

Lilly oncology image

Lilly app aims to boost trial recruitment

June 8, 2012
Medical Communications GSK, clinical trials, lilly, oncology

Lilly has launched a new searchable clinical trial mobile app for oncologists. The app is available for the iPad and …

John Lechleiter

Lechleiter wants policy that spurs innovation

June 8, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Lechleiter, Obama, PhRMA, US, heathcare, lilly

Lilly’s leader is calling on governments to take the long-term view when it comes to healthcare policy. John Lechleiter who …

screen_shot_2012-06-06_at_10

William Kaelin Jr elected to Lilly board

June 6, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Kaelin, lilly

Eli Lilly has elected William Kaelin Jr to its board of directors. Dr Kaelin, 54, is a Professor in the Department of …

lechleiter_john_300dpi

Lilly’s John Lechleiter elected as PhRMA Board chairman

April 17, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, John Lechleiter, Pfizer, Sanofi, lilly

John Lechleiter, chairman, president and chief executive of Lilly has been elected chairman of the Pharmaceutical Research and Manufacturers of …

Alzheimer’s diagnostic comes with caveats

April 10, 2012
Sales and Marketing Alzheimer's, Amyvid, lilly

A first-in-class test for Alzheimer’s disease has been approved by the FDA, but its makers have stressed its limitations.Lilly’s Amyvid …

The Gateway to Local Adoption Series

Latest content